AI Article Synopsis
Article Abstract
A 54-year-old African American male with systemic lupus erythematosus and chronic alcoholic hepatitis presented with recurrent fever, pancytopenia, transaminitis, weight loss, and widespread violaceous tender plaques. Skin biopsy revealed hemophagocytic histiocytes leading to a diagnosis of cytophagic histiocytic panniculitis in the setting of lupus panniculitis. During workup, an axillary lymph node biopsy mimicked Kikuchi-Fujimoto's disease. Treatment with tapering high-dose glucocorticoids, mycophenolate mofetil, and hydroxychloroquine induced remission of the disease. We believe the comorbid conditions of Kikuchi-Fujimoto-like pathology and cytophagic histiocytic panniculitis have not been documented in the literature to date in a patient with systemic lupus erythematosus.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547667 | PMC |
| http://dx.doi.org/10.7759/cureus.28951 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinicopathological Characteristics and Outcome of Cytophagic Histiocytic Panniculitis: A Single-Center, Retrospective Study.
Clin Cosmet Investig Dermatol
May 2024
Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Background: Cytophagic histiocytic panniculitis (CHP) is a rare panniculitis associated with systemic features characterized by the infiltration of subcutaneous adipose tissue by benign-appearing T lymphocytes and phagocytic histiocytes, mimicking hemophagocytic lymphohistiocytosis (HLH) and subcutaneous panniculitis-like T-cell lymphoma (SPTCL).
Purpose: To establish the clinicopathological features and response to treatment of CHP and evaluate the prognosis of patients and guide therapy based on the current state of knowledge.
Material And Methods: Clinical, laboratory, histopathological, and outcome data of 12 patients with CHP were retrospectively collected between 2009 and 2022.
Cytophagic histiocytic panniculitis leading to a diagnosis of acute myeloid leukemia with monocytic differentiation: A case report and literature review.
J Cutan Pathol
September 2024
Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Article Synopsis
- Cytophagic histiocytic panniculitis (CHP) is a condition characterized by benign phagocytic histiocytes that can engulf blood cells and is linked to various systemic diseases.
- A case study is presented about a 72-year-old woman who exhibited a skin rash resembling pityriasis lichenoides et varioliformis acuta (PLEVA), leading to a detailed skin biopsy.
- Ultimately, the biopsy indicated CHP, which triggered further investigations that revealed the patient had an underlying acute monocytic leukemia of myeloid lineage.
Cytophagic Histiocytic Panniculitis Presenting as Subcutaneous Nodules and Generalized Edema - A Case Report.
Clin Cosmet Investig Dermatol
December 2023
Department of Dermatology, School of Medicine, Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
Background: Cytophagic histiocytic panniculitis (CHP) is a rare form of nodular panniculitis characterized by clinical manifestations such as skin erythema, nodules, fever, pancytopenia, liver failure, plasmacytosis, and hepatosplenomegaly. We report a case of CHP that was initially misdiagnosed as subcutaneous panniculitis-like T-cell lymphoma (SPTCL) but achieved complete remission with a favorable prognosis.
Methods: A 38-year-old female presented to the dermatology department with a 15-day history of subcutaneous nodules, generalized edema, and continuous fever.
Panniculitis: A Cardinal Sign of Autoinflammation.
Curr Rheumatol Rev
June 2024
Trofa Saúde Gaia, Rua Fernão de Magalhães nº 2 Fr E, 4404-501 Vila Nova de Gaia, Portugal.
Panniculitis was first described in the nineteenth century and is characterized by inflammation of the subcutaneous fat. It may be categorized in septal or lobular subtypes, but other histopathological features (e.g.
View Article and Find Full Text PDFAvoid a rash diagnosis: reconsidering cytophagic histiocytic panniculitis as a distinct clinical-pathologic entity.
JAAD Case Rep
June 2023
Children's Hospital of Philadelphia, Division of Rheumatology, Philadelphia, Pennsylvania.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!